Landsburg DJ, Barta SK, Ramchandren R, Batlevi C, et al. Fimepinostat (CUDC-907) in patients with relapsed/refractory diffuse large B cell and high-grade B-cell lymphoma: report of a phase 2 trial and exploratory biomarker analyses. Br J Haematol 2021 Aug 2. doi: 10.1111/bjh.17730.
PMID: 34341990